Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and ten have given a buy rating to the company. The average […]